Dear Reader,
It’s rare we get good news anymore.
But for a moment, I want you to set aside the doom and gloom you’re seeing in the mainstream press.
Because if you let yourself get distracted at a time like this, you may be missing the most important financial opportunity of the 21st century.
I’m talking about a technology codenamed, “CTX.” |
Even with the rest of the world looking elsewhere, quietly, elites like Elon Musk, Bill Gates, and Jeff Bezos are all pouring their wealth into this breakthrough.
Nobel Prize-winning scientists are hailing it as a potential end of human disease as we know it.
The FDA has already granted 4 different “Fast Track” and “Greenlight” designations — speeding it through the approval process.
And its genesis launch is on course to roll out shortly.
This “CTX” technology could soon siphon trillions of dollars into one tiny corner of the biotech industry. |
And I want you to be ready before this happens.
Because the last time biotech had a catalyst like this hit, the unthinkable occurred.
Starting in the ’90s, stocks like Gilead soared 56,000%… Biogen went up 100,000%… and Amgen skyrocketed 300,000%.
Could biotech be getting ready for another “revolution” like it saw in the 1990s? I believe the answer is a resounding YES — for the select few companies that own the rights to “CTX.”
For details, please click here. |
Regards,
Jeff Brown
Founder, Brownstone Research |
